KRIYA THERAPEUTICS
Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to engineer, manufacture, characterize, and develop new gene therapies
KRIYA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.kriyatherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
+1 833 574 9289
Email Addresses:
[email protected]
Total Funding:
450.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Contact Form 7 Cloudflare Cloudflare Network Error Logging
Similar Organizations
Code Biotherapeutics
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Lycia Therapeutics
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
CAM Capital
CAM Capital investment in Series C - Kriya Therapeutics
Alumni Ventures
Alumni Ventures investment in Series C - Kriya Therapeutics
Narya Capital
Narya Capital investment in Series C - Kriya Therapeutics
Bluebird Ventures
Bluebird Ventures investment in Series C - Kriya Therapeutics
JDRF T1D Fund
JDRF T1D Fund investment in Series C - Kriya Therapeutics
QVT Financial
QVT Financial investment in Series C - Kriya Therapeutics
Transhuman Capital
Transhuman Capital investment in Series C - Kriya Therapeutics
Lightswitch Capital
Lightswitch Capital investment in Series C - Kriya Therapeutics
Dexcel Pharma
Dexcel Pharma investment in Series C - Kriya Therapeutics
Foresite Capital
Foresite Capital investment in Series C - Kriya Therapeutics
Key Employee Changes
Official Site Inspections
http://www.kriyatherapeutics.com Semrush global rank: 4.01 M Semrush visits lastest month: 3.09 K
- Host name: 104.26.6.203
- IP address: 104.26.6.203
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kriya Therapeutics"
Our Team: Leaders in Gene Therapy - Kriya Therapeutics
Prior to SpringWorks, Lily was Senior Director of Program Management at Roivant Sciences where she led planning and organization of drug development projects through NDA preparation and coordination of due diligence reviews …See details»
Kriya Therapeutics - Crunchbase Company Profile
Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to …See details»
Shankar Ramaswamy, MD - Kriya Therapeutics
Shankar Ramaswamy is the Co-Founder, Chairman, and Chief Executive Officer of Kriya Therapeutics. Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, where he was responsible for helping to identify and …See details»
Kriya Therapeutics, Inc. | LinkedIn
Kriya Therapeutics, Inc. is a biopharmaceutical company developing gene therapies for diseases affecting millions of people around the world. With operations in Palo Alto, California and Research ...See details»
Kriya Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kriya Therapeutics, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Shankar Ramaswamy, M.D. - Kriya Therapeutics | LinkedIn
Dr. Ramaswamy is the Co-Founder and CEO of Kriya Therapeutics, a biopharmaceutical… · Experience: Kriya Therapeutics · Education: Harvard University · Location: Raleigh-Durham-Chapel Hill ...See details»
Kriya Therapeutics CEO and Key Executive Team | Craft.co
Kriya Therapeutics's Co-Founder, Chairman, and Chief Executive Officer is Shankar Ramaswamy. Other executives include Roger Jeffs, Co-Founder and Vice Chairman; Fraser …See details»
Kriya Therapeutics - Craft
May 17, 2020 Kriya Therapeutics is a gene therapy company. It is focused on designing and developing transformative treatments. Kriya Therapeutics' initial pipeline includes multiple AAV …See details»
Kriya Therapeutics To Grow Gene Therapy …
May 26, 2020 There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar Ramaswamy, former chief …See details»
Kriya Therapeutics, Inc.: Culture | LinkedIn
Kriya Therapeutics, Inc. Biotechnology Research Palo Alto, California 15,699 followers A fully integrated platform company aiming to revolutionize how gene therapies are designed, …See details»
Kriya Announces $150 Million Addition to its Series C, Bringing …
Jul 26, 2023 PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc., a biopharmaceutical company developing …See details»
Kriya Appoints Scientific Co-Founder J. Fraser Wright, Ph.D., as …
Jul 8, 2024 – Dr. Wright has three decades of experience in the research and development of viral vectors and has been involved in the development of multiple approved gene therapies …See details»
Kriya Therapeutics announces $80 million Series A financing to …
May 12, 2020 PALO ALTO, Calif. and DURHAM, N.C., May 12, 2020 /PRNewswire/ -- Kriya Therapeutics announced today that it has raised $80.5 million in a Series A financing to fund …See details»
Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to …
Nov 16, 2022 Approximately 10,000 to 15,000 new cases of TN occur each year in the U.S., according to the National Organization for Rare Disorders (NORD). While currently available …See details»
Working at Kriya Therapeutics - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Kriya Therapeutics, including salaries, reviews, office photos, and more. This is the Kriya Therapeutics company profile.See details»
Kriya Announces $150 Million Addition to its Series C, Bringing …
Jul 26, 2023 – Kriya’s therapeutic pipeline addresses a broad range of diseases that collectively affect millions of patients worldwide—with a goal of delivering transformational clinical benefits …See details»
Kriya Highlights Positive Preclinical Data for KRIYA-586, a
Sep 12, 2024 – Preclinical data demonstrate pharmacodynamic activity of KRIYA-586, an investigational gene therapy which encodes for an anti-IGF1R antibody –– Kriya anticipates …See details»
Newsroom: Gene Therapy Pipeline News - Kriya Therapeutics
Kriya shares the latest news on our pipeline of life-changing gene therapies to address common diseases.See details»
Pipeline: One-Time Gene Therapies to Address Common Diseases
Therapeutic Area Program Disease Mechanism Discovery Research IND-Enabling Clinical; Ophthalmology: KRIYA-825: Geographic Atrophy: Anti-C3 and C5See details»